WHC is still in active development. Read this to understand our approach.
depiction of YEJRWHAVMIAJKC-UHFFFAOYSA-N.svg
tripsit

gbl

Verificar en tripsit

psychonaut

GBL

Verificar en psychonaut

isomerdesign

GBL

Verificar en isomerdesign

pubchem

gamma-Butyrolactone

Verificar en pubchem

druglab

GBL

Verificar en druglab

drugmap

Gamma-butyrolactone

Verificar en drugmap

Data

InChI: InChI=1S/C4H6O2/c5-4-2-1-3-6-4/h1-3H2

Sinónimos: FEMA No. 3291,gamma-Butyrolactone-13C4,gamma-Butyrolactone (natural),Agrisynth BLO,Butyryl lactone,1,4-Lactone,CAS-96-48-0,1,4-Butyrolactone,4-Hydroxybutyric acid lactone,Dihyro-2-furanone,96-48-0,Butyrylactone,848486-92-0,2(3H)-dihydrofuranone,.alpha.-Butyrolactone, 2-oxolanone,CCRIS 2924,4-Butanolide,DTXCID80224,Butyric acid, 4-hydroxy-, gamma-lactone,No Go,GAMMA-BUTYROLACTONE [HSDB],dihydrofuran-2(3H)-one,Gamma-Lactone 4-hydroxybutyric acid,gamma-Butyrolactone, >=99% (GC),Gamma-Lactone 4-hydroxy-butanoic acid,ZINC4658567,J-513020,gamma-Butyrolactone,NCGC00258044-01,NCI-C55878,BUTYROLACTONE [VANDF],DB04699,Q79739,4-Deoxytetronic acid,BLON,4,5-Dihydro-2(3H)-furanone,4-Butyrolactone,DSSTox_RID_75445,gamma-Butyrolactone, SAJ first grade, >=99.5%,1,4-Butanolide,B0767,CHEBI:42639,EINECS 202-509-5,FT-0664178,Blue Nitro,4-butanolactone,STL281877,g-Butyrolactone,Dihydro-(3 H)-furan-2-one,Butyric acid, 4-hydroxy-, .gamma.-lactone,gamma-Butyrolactone solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material,NSC 4592,AKOS000119924,2-Oxolanone,.gamma.-Butanolactone,A4867,gamma-Butyrolactone, puriss., >=99.0% (GC),Dynasolve 699 (Salt/Mix),GH Revitalizer,Butanoic acid, 4-hydroxy-, .gamma.-lactone,1-Oxacyclopentane-2-one,LS40356,gama-Butyrolactone,4-Hydroxybutanoic acid lactone,NSC-4592,γ-Butyrolactone,gamma-Butyryllactone,GAMMA-BUTYROLACTONE [IARC],EC 202-509-5,1,2-Butanolide,DSSTox_CID_224,EPA Pesticide Chemical Code 122303,gamma-Hydroxybutyric acid lactone,CHEMBL95681,gamma-Butanolactone,.gamma.-Hydroxybutyrolactone,NIH 10540,2-Oxotetrahydrofuran,tetrahydrofuran-2-one,GBL,gamma-Hydroxybutyrolactone,.gamma.-Hydroxybutyric acid lactone,gamma-Butyrolactone (GBL) 1.0 mg/ml in Acetonitrile,Gamma-Lactone 4-hydroxybutanoic acid,C01770,.GAMMA.-BUTYROLACTONE [FHFI],Paint Clean G,BL,g-Hydroxybutyric acid lactone,4-Hydroxybutanoic acid lactone, >=98%, FCC, FG,C-1070,4 Hydroxybutyric Acid Lactone,31213-03-3,gamma-Hydroxybutyric Acid cyclic ester,dihydrofuran-2-one,Butyric acid, .gamma.-lactone,DSSTox_GSID_20224,BUTYROLACTONE,Caswell No. 132B,4-Hydroxybutyric acid, .gamma.-lactone,Butanoic acid, .gamma.-lactone,gamma-butyrolacton,Butyric acid lactone,NCGC00253913-01,g-Butalactone,2,3,4,5-Tetrahydro-2-furanone,Butanoic acid, 4-hydroxy-, gamma-lactone,gamma-Butalactone,LMFA07040004,NCGC00247920-01,BUTYROLACTONE [MI],GAMMA-BUTYROLACTONE [FCC],2(3H)-Furanone, dihydro-, homopolymer,dihydro-furan-2-one,.gamma.-Hydrooxybutyric acid lactone,.gamma.-6480,.gamma.-BL,gamma-Butyrolactone, ReagentPlus(R), >=99%,1-Oxacyclopentan-2-one,BUTYROLACTONE [INCI],GTPL5462,LBG 11785,Gammabutyrolactone (GBL),Tox21_300188,Revivarant,Tetrahydro-2-furanone,DTXSID6020224,gamma-butyro-lactone,HSDB 4290,UNII-OL659KIY4X,4-Deoxytetronate,FT-0664177,.gamma.-Hydroxybutyric acid cyclic ester,gamma-BL,BLO,Gamma-Lactone 4-hydroxy-butyric acid,Remforce,NSC4592,Dihydro-2-furanone,Q-200482,BUTANOIC ACID,4-HYDROXY,LACTONE GAMMA-BUTYROLACTONE,2(3H)-Furanone, dihydro-,J-520327,oxolan-2-one,BUTYROLACTONE [WHO-DD],4-Hydroxybutanoic acid, .gamma.-lactone,MFCD00005386,gamma Butyrolactone,gammabutyrolactone,.gamma.-Butyrolactone,gamma-6480,gamma-Butyrolactone, analytical standard,OL659KIY4X,g-Butyryllactone,Dihydro-2(3H)-furanone,tetrahydrofuranone,4-hydroxy-Butanoic acid g-lactone,AI3-28121,WLN: T5OVTJ,Tox21_200490,NCGC00247920-02,4-butanolide


Estimated data

Solubilidad: 0.749 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 60.0% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.